Table 4.
Effect | Effect level | Odds ratio (95%CI) | P-value |
---|---|---|---|
Viral test | 1: Negative | 0.78 (0.74, 0.82) | <.0001 |
2: Positive | 0.66 (0.58, 0.75) | ||
0: No test | Reference | ||
Age | Per year | 1.03 (1.02, 1.03) | <.0001 |
Male | 0.98 (0.94, 1.02) | 0.2878 | |
Race | Black | 0.89 (0.84, 0.96) | 0.0095 |
Hispanic | 0.78 (0.59, 1.03) | ||
Others | 0.99 (0.92, 1.07) | ||
Unknown | 1.11 (0.61, 2.02) | ||
White | Reference | ||
Insurance status | Commercial Indemnity | 0.83 (0.71, 0.98) | 0.0448 |
Managed Care | 0.88 (0.78, 0.99) | ||
Medicaid | 0.86 (0.76, 0.97) | ||
Medicare | 0.85 (0.77, 0.95) | ||
Others | Reference | ||
Teaching hospital | 0.88 (0.76, 1.02) | 0.0906 | |
Urban hospital | 0.97 (0.82, 1.16) | 0.769 | |
Bed size | 201–400 | 1.11 (0.96, 1.29) | 0.0345 |
>400 | 1.27 (1.06, 1.52) | ||
≥200 beds | Reference | ||
Hospital region | Midwest | 0.7 (0.57, 0.85) | 0.0005 |
Northeast | 0.95 (0.76, 1.19) | ||
South | 0.83 (0.69, 1.00) | ||
West | Reference | ||
Combined comorbidities | 1.07 (1.06, 1.08) | <.0001 | |
Organ failure score | 1.7 (1.67, 1.74) | <.0001 | |
Chronic pulmonary disease | 0.76 (0.73, 0.79) | <.0001 | |
Pulmonary circulation disease | 1.22 (1.14, 1.3) | <.0001 | |
Congestive heart failure | 1.08 (1.03, 1.13) | 0.001 | |
Diabetes | 0.81 (0.78, 0.85) | <.0001 | |
Cancer | 2.38 (2.25, 2.53) | <.0001 | |
Paralysis | 1.18 (1.08, 1.28) | 0.0002 | |
Obesity | 0.76 (0.72, 0.82) | <.0001 | |
Liver disease | 1.36 (1.23, 1.49) | <.0001 | |
Peripheral vascular disease | 0.99 (0.93, 1.05) | 0.7043 | |
Admit from SNF | 1.43 (1.34, 1.52) | <.0001 | |
Dialysis | 0.87 (0.8, 0.95) | 0.0014 | |
Previous admission (w/i 6 mo) | 1.32 (1.25, 1.39) | <.0001 | |
ICU | 1.63 (1.55, 1.71) | <.0001 | |
IMV | 1.61 (1.52, 1.71) | <.0001 | |
Vasopressor | 1.77 (1.67, 1.88) | <.0001 | |
Oral medication | 0.61(0.58, 0.63) | <.0001 |
Note. SNF, skilled nursing facility; ICU, intensive care unit; IMV, intermittent mandatory ventilation.
Adjusted for basic demographics, insurance status, hospital location (urban vs rural), Census Bureau major geographic region, various comorbidities, and markers of severity on admission.